Howard Hughes Medical Institute’s Johnson & Johnson JNJ Stock Holding History

Howard Hughes Medical Institute’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-520	Closed	-$108K	–	274
2025 Q4	$108K	Buy	520 +2	+0.4%	+$395	0.06%	16
2025 Q3	$96K	Sell	518 -2	-0.4%	-$343	0.06%	20
2025 Q2	$79.4K	Buy	+520	New	+$79.9K	0.03%	21

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Howard Hughes Medical Institute's JNJ Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 520 shares — an estimated $108K sold.

Howard Hughes Medical Institute first reported a position in JNJ in Q2 2025 and held it in 3 quarters. The position peaked at $108K in Q4 2025. 4,626 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 520 Johnson & Johnson shares in Q1 2026, an estimated $108K.
Howard Hughes Medical Institute first reported a position in Johnson & Johnson in Q2 2025 and held it in 3 quarters.
Howard Hughes Medical Institute's Johnson & Johnson position peaked at $108K in Q4 2025.
4,626 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.